Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NADIA YIMER

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1073000618
CMS profile
11643585
Location
WINDER, GA

General Payments · PY2024

$5,906.14

  • Reported across 20 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,906.14

20 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Education $5,500.00 3
Food and Beverage $406.14 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $5,906.14 20

Payment records · PY2024 (20)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $20.35 10/24/2024 Food and Beverage Undisputed 01/23/2026 1078884745 CMS
Amgen Inc. $22.69 09/18/2024 Food and Beverage Undisputed 01/23/2026 1116218968 CMS
Amgen Inc. $20.63 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116218972 CMS
Amgen Inc. $15.87 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116218976 CMS
AstraZeneca Pharmaceuticals LP $23.24 11/18/2024 Food and Beverage Undisputed 01/23/2026 1105750565 CMS
AstraZeneca Pharmaceuticals LP $29.99 12/02/2024 Food and Beverage Undisputed 01/23/2026 1105585008 CMS
AstraZeneca Pharmaceuticals LP $23.26 12/11/2024 Food and Beverage Undisputed 01/23/2026 1104331854 CMS
Baxter Healthcare $16.04 09/30/2024 Food and Beverage Undisputed 01/23/2026 1120626653 CMS
GENZYME CORPORATION $37.13 10/23/2024 Food and Beverage Undisputed 01/23/2026 1139716394 CMS
GlaxoSmithKline, LLC. $19.70 10/15/2024 Food and Beverage Undisputed 01/23/2026 1116025039 CMS
Insmed, Inc. $34.11 10/29/2024 Food and Beverage Undisputed 01/23/2026 1089570822 CMS
INTUITIVE SURGICAL, INC. $2,500.00 10/18/2024 Education Undisputed 01/23/2026 1137104469 CMS
INTUITIVE SURGICAL, INC. $16.99 10/18/2024 Food and Beverage Undisputed 01/23/2026 1137151903 CMS
INTUITIVE SURGICAL, INC. $1,500.00 11/19/2024 Education Undisputed 01/23/2026 1137122041 CMS
INTUITIVE SURGICAL, INC. $3.37 12/03/2024 Food and Beverage Undisputed 01/23/2026 1137099738 CMS
INTUITIVE SURGICAL, INC. $1,500.00 12/03/2024 Education Undisputed 01/23/2026 1137196083 CMS
Mylan Specialty L.P. $43.77 12/05/2024 Food and Beverage Undisputed 01/23/2026 1147367584 CMS
Regeneron Healthcare Solutions, Inc. $35.84 10/03/2024 Food and Beverage Undisputed 01/23/2026 1114259398 CMS
Regeneron Healthcare Solutions, Inc. $21.71 11/21/2024 Food and Beverage Undisputed 01/23/2026 1114259400 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.45 12/10/2024 Food and Beverage Undisputed 01/23/2026 1137701042 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.